Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Illinois pilot program tracks PSE

This article was originally published in The Tan Sheet

Executive Summary

Six Illinois counties begin electronically tracking pharmacy purchases of nonprescription products containing pseudoephedrine June 15 as part of a pilot program overseen by the Southern Illinois Enforcement Group. The Illinois State Police Precursor Tracking Program is slated for evaluation after eight months to determine the feasibility of a statewide system for monitoring purchases of methamphetamine precursors. Tom McNamara, special projects coordinator for Carbondale-based SIEG, said in an interview the e-tracking system is online but will not be fully operational until Aug. 17. In March, Iowa became the seventh state to mandate electronic tracking for purchases of meth ingredients (1"The Tan Sheet" April 6, 2009, In Brief)

You may also be interested in...



Iowa to track meth precursors

Gov. Chet Culver (D) signs a law establishing a real-time electronic repository to monitor sales of ephedrine- and pseudoephedrine-containing products in Iowa. Senate File 237, enacted March 25 and effective July 1, makes Iowa the seventh state to mandate electronic logbooks for purchases of nonprescription methamphetamine precursors, according to the National Association of Chain Drug Stores. Oklahoma, Arkansas, Kentucky and West Virginia actively track PSE sales. Hawaii and Missouri have approved but have yet to implement systems. The Kansas Senate has approved an electronic logbook bill (1"The Tan Sheet" March 16, 2009, In Brief)

Patent Board Rejects Edwards’ Heart Valve Claim-Review Request

The US Patent Office has rejected a request by Edwards LifeSciences to review an Abbott patent on heart-valve technology, which could establish the patent as a key part of Abbott Laboratories’ arguments in a larger ongoing intellectual property case.

Industry Ignored In Dispute Over UK Retailer’s ‘Weight Management’ Claim

Despite being defended by four industry representative bodies, UK health food retailer Holland & Barrett has been rapped for its use of “weight management” as a product category on its consumer-facing website by the country's Advertising Standards Authority. 

Topics

UsernamePublicRestriction

Register

PS103042

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel